Christopher Gibson
Papers
1
Total Citations
3
H-Index
1
About
Dr. Christopher Gibson is a leading expert in the diagnosis and management of gastroenteropancreatic neuroendocrine tumors (NETs), with a particular focus on incidental findings during routine endoscopy. His seminal 2023 work, "Early Definitive Diagnosis and Management of Incidental Neuroendocrine Tumors Found on Gastrointestinal Endoscopy," has garnered 3 citations and provides a critical framework for clinicians navigating the rising incidence of these often-indolent tumors. By addressing the clinical challenge of distinguishing clinically significant NETs from benign lesions, Dr. Gibson’s research directly impacts patient outcomes through evidence-based guidelines for early intervention. His contributions advance the field by integrating modern diagnostic modalities with surgical and medical management strategies, reducing unnecessary procedures while ensuring timely treatment for aggressive subtypes. Dr. Gibson’s work is essential reading for gastroenterologists and oncologists, offering a practical roadmap for a condition whose detection is accelerating with improved endoscopic technology.
Research Focus
Key Achievements
Top Papers
- 1